{"id":"W3135647768","doi":"10.1038/s41375-021-01179-4","title":"Midostaurin reduces relapse in FLT3-mutant acute myeloid leukemia: the Alliance CALGB 10603/RATIFY trial","year":2021,"lang":"en","type":"article","venue":"Leukemia","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":98,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Novartis; U.S. Department of Health and Human Services","keywords":"Midostaurin; Medicine; Internal medicine; Cytarabine; Oncology; Cumulative incidence; Myeloid leukemia; Preleukemia; Maintenance therapy; Transplantation; Surgery; Leukemia; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00129483,0.0006081503,0.001058411,0.0002062875,0.0003241092,0.0001825065,0.0008375362,0.0006711348,0.0007583978],"category_scores_gemma":[0.001378936,0.0004523743,0.0003856843,0.001804083,0.0004812965,0.0003058376,0.0005195796,0.003021047,0.0007000769],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.007817882,"about_ca_system_score_gemma":0.01006724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006269428,"about_ca_topic_score_gemma":0.0004288315,"domain_scores_codex":[0.9942663,0.0005554752,0.001162714,0.001260334,0.001345405,0.001409816],"domain_scores_gemma":[0.9964479,0.0006593493,0.0002513785,0.001783387,0.0003730292,0.0004849284],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.06969684,0.0007824759,0.002360873,0.0005467453,0.001878697,0.03515812,0.00597538,0.0005578736,0.6515319,0.003280938,0.1795072,0.04872293],"study_design_scores_gemma":[0.1908664,0.00212946,0.01273139,0.001369364,0.001049781,0.003695776,0.003850109,0.007151049,0.5482618,0.001675137,0.22504,0.002179741],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9703875,0.002642111,0.00004600749,0.01372779,0.0009231287,0.001808364,0.00005262105,0.0001852073,0.01022723],"genre_scores_gemma":[0.9484856,0.003962472,0.002350104,0.003910599,0.002118862,0.0005670351,0.0002661803,0.0002064657,0.03813275],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1211696,"threshold_uncertainty_score":0.9997928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02581105720882084,"score_gpt":0.3097408282084322,"score_spread":0.2839297709996114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}